Supplemmentary Methods from Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2<sup>−/−</sup>IL2Rγ<sup>null</sup> Immunodeficient Mice
crossref(2023)
摘要
Supplementary methods Appendix
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要